Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation

Published:2014-01-05 Issue:1 Volume:9 Page:85-90
ISSN:1558-8211
Container-title:Current Hematologic Malignancy Reports
language:en
Short-container-title:Curr Hematol Malig Rep

Author:

Callejas-Díaz Alejandro,Gea-Banacloche Juan C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11899-013-0193-y.pdf

Reference34 articles.

1. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008;46(4):497–504.

2. Centers for Disease Control and Prevention (CDC). Vital signs: preventing clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157–62.

3. Lessa FC, Gould CV, McDonald LC. Current status of clostridium difficile infection epidemiology. Clin Infect Dis. 2012;55 Suppl 2:S65–70.

4. Dubberke ER, Reske KA, Srivastava A, Sadhu J, Gatti R, Young RM, et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant. 2010;24(2):192–8.

5. Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant. 2000;26(8):871–6.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial prophylaxis and the rate of blood stream infections and Clostridioides difficile in pediatric stem cell transplantation: A single‐center retrospective study;Pediatric Transplantation;2022-08-10

2. Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant;Transplant Infectious Disease;2022-01-25

3. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients;Transplantation and Cellular Therapy;2021-12

4. Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease;Transplantation and Cellular Therapy;2021-02

5. Antimicrobial Stewardship;Hematologic Malignancies;2020-10-22